Literature DB >> 307459

Effect of doxycycline on transmission of Vibrio cholerae infection among family contacts of cholera patients in Calcutta.

P G Gupta, B K Sircar, S Mondal, S P De, D Sen, S N Sikder, B C Deb, S C Pal.   

Abstract

Doxycycline was used among the family contacts of hospitalized cholera patients in Calcutta to determine its effectiveness in controlling transmission of V. cholerae infection. A total of 137 such contacts were given a single oral dose of doxycycline in graded doses according to age. A similar group of 139 contacts received a single dose of multivitamins as placebo. All 276 contacts were examined bacteriologically daily for 10 days for the presence of V. cholerae in their stools. The results showed that doxycycline was effective in significantly reducing the load of V. cholerae infection for up to 5 days following treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307459      PMCID: PMC2395570     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Cholera: lessons from haiti and beyond.

Authors:  Ana A Weil; Louise C Ivers; Jason B Harris
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis.

Authors:  I de Zoysa; R G Feachem
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Clinical outcomes in household contacts of patients with cholera in Bangladesh.

Authors:  Ana A Weil; Ashraful I Khan; Fahima Chowdhury; Regina C Larocque; A S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

Review 4.  Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.

Authors:  Ludovic Reveiz; Evelina Chapman; Pilar Ramon-Pardo; Tracey Perez Koehlmoos; Luis Gabriel Cuervo; Sylvain Aldighieri; Amy Chambliss
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.